Abeona Therapeutics Q3 2025 Earnings Preview
Source: SeekingAlpha
2025-11-11 11:39:12 ET
More on Abeona Therapeutics
- Abeona Therapeutics: Zevaskyn Data Key In Gauging Momentum - Why I Hold
- Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript
- Abeona Therapeutics: AAV204 Capsid Could Be Next Growth Prospect Beyond Zevaskyn
- Seeking Alpha’s Quant Rating on Abeona Therapeutics
- Historical earnings data for Abeona Therapeutics
Read the full article on Seeking Alpha
For further details see:
Abeona Therapeutics Q3 2025 Earnings Preview
Abeona Therapeutics Inc.
NASDAQ: ABEO
ABEO Trading
-0.21% G/L:
$4.82 Last:
458,265 Volume:
$4.92 Open:
ABEO Latest News
March 09, 2026 07:30:00 am
Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
March 03, 2026 07:30:00 am
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
February 09, 2026 10:04:41 am
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2025 07:30:00 am
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
ABEO Stock Data
$282,066,034
45,791,700
6.07%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
Cleveland
